|
Significance of stem cell marker Lgr5 expression in colorectal carcinogenesis
|
|
Value of CD34 and CD10 immunostaining in the differentiation between basal cell carcinoma and trichoepithelioma
|
|
Prognostic value of CD44 and Her2/neu in invasive transitional cell carcinoma of the urinary bladder
|
|
Value of p53, ki-67 and CD10 in differentiation between keratoacanthoma and squamous cell carcinoma
|
|
Evaluation of galectin-3, β-catenin, and nuclear morphometry in different thyroid lesions
|
|
Differential expression of p16 INK4aprotein and S100A4 protein in gastric carcinoma.
|
|
Assessment of Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM6) in pancreatic ductal adenocarcinoma, a combined serum and immunohistochemical study
|
|
Combined serum and immunohistochemical differentiation between reactive, and malignant mesothelial proliferations
|
|
Significance of tumoral and stromal ALDH 1A1 expression in
breast invasive duct carcinoma in Egyptian female patients
|
|
Relation of autophagy to apoptosis and progesterone receptor
expression in endometrial carcinoma type I
|
|
Evaluation of Cancer-Associated Fibroblasts Markers in Hepatocellular Carcinoma
|
|
Hepatic expression of programmed death-1 (PD-1)
and its ligand, PD-L1, in children with autoimmune
hepatitis: relation to treatment response
|
|
Significance of BRAF and Nrf2 in evaluation of serous ovarian
tumors
|
|
EVALUATION O F THE ROLE OF TIGHT JUNCTION
MOLECULES; CLAUDIN-1 AND CLAUDIN-4 IN UROTHELIAL
NEOPLASMS
|
|
|
Evaluation of the Expression and Role of Adenosine Receptor (A2aR) and PDL-1 in Bladder Urothelial Carcinoma
|
|
|
Studying the role of IMP3 and P53 in detection of dysplastic changes in Barrett's esophagus
|
|